Why Is T2 Biosystems (TTOO) Stock Up 30% Today?
TTOO stock is climbing over 30% after the Food and Drug Administration ruled that T2 Biosystems can sell its new biothreat test.
Stay updated with breaking news from Bacteria Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TTOO stock is climbing over 30% after the Food and Drug Administration ruled that T2 Biosystems can sell its new biothreat test.
T2 Biosystems (NASDAQ: TTOO) has gained significant traction and attention in recent weeks. Here's more on what's happening behind the scene.
Operator: Greetings. Welcome to T2 Biosystems, Inc. Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Received FDA Breakthrough Device Designation for Candida auris test, achieved record quarterly sepsis test panel orders and received second largest sepsis driven T2Dx® Instrument order LEXINGTON,...
The Tech-heavy Nasdaq 100 index has been on an impressive rally, soaring by over 40% year to date, driven by the remarkable gains from tech giants and their exponential growth in the artificial...